Clínica de Marly S.A. (BVC:MARLY)
Colombia · Delayed Price · Currency is COP 8,500.00
0.00 (0.00%)
At close: Sep 11, 2026
Clínica de Marly Ratios and Metrics
Market cap in millions COP. Fiscal year is January - December.
Millions COP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 90,763 | 90,763 | 90,763 | 90,763 | 90,763 | 68,339 | |
Market Cap Growth | 0% | 0% | 0% | 0% | 32.81% | 0% |
Enterprise Value | -192,829 | -153,780 | -85,715 | -14,278 | 6,770 | 15,134 |
Last Close Price | 8500.00 | 7269.85 | 5981.32 | 5228.12 | 4896.87 | 2349.95 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 0.97 | 1.04 | 1.03 | 1.40 | 1.66 | 1.40 |
PS Ratio | 0.20 | 0.21 | 0.22 | 0.25 | 0.28 | 0.25 |
PB Ratio | 0.12 | 0.13 | 0.14 | 0.16 | 0.18 | 0.19 |
P/TBV Ratio | 0.12 | 0.13 | 0.14 | 0.16 | 0.18 | 0.20 |
P/FCF Ratio | 5.84 | 2.90 | - | 3.90 | 3.30 | 4.14 |
P/OCF Ratio | 2.69 | 1.66 | 10.08 | 2.82 | 1.97 | 2.13 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | - | - | - | 0.02 | 0.05 |
EV/EBITDA Ratio | - | - | - | - | 0.09 | 0.22 |
EV/EBIT Ratio | - | - | - | - | 0.10 | 0.24 |
EV/FCF Ratio | - | - | - | - | 0.25 | 0.92 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.09 |
Debt / EBITDA Ratio | 0.02 | 0.03 | 0.06 | 0.15 | 0.30 | 0.47 |
Debt / FCF Ratio | 0.17 | 0.10 | - | 0.57 | 0.81 | 1.95 |
Net Debt / Equity Ratio | -0.39 | -0.39 | -0.34 | -0.24 | -0.16 | -0.21 |
Net Debt / EBITDA Ratio | -2.55 | -2.48 | -1.98 | -1.52 | -1.05 | -1.08 |
Net Debt / FCF Ratio | -18.66 | -8.89 | 512.92 | -5.77 | -2.87 | -4.54 |
Asset Turnover | 0.53 | 0.54 | 0.56 | 0.54 | 0.58 | 0.64 |
Inventory Turnover | 43.87 | 38.29 | 37.95 | 35.83 | 35.82 | 32.16 |
Quick Ratio | 4.24 | 4.80 | 4.08 | 3.08 | 2.77 | 3.02 |
Current Ratio | 4.31 | 4.92 | 4.19 | 3.17 | 2.87 | 3.12 |
Return on Equity (ROE) | 13.49% | 13.05% | 14.78% | 12.11% | 12.80% | 14.93% |
Return on Assets (ROA) | 7.84% | 8.18% | 8.79% | 7.67% | 7.84% | 9.14% |
Return on Invested Capital (ROIC) | 17.02% | 17.03% | 17.03% | 13.16% | 13.17% | 16.35% |
Return on Capital Employed (ROCE) | 13.50% | 13.90% | 15.00% | 13.40% | 12.10% | 16.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 103.26% | 96.33% | 96.66% | 71.26% | 60.14% | 71.66% |
FCF Yield | 17.14% | 34.45% | -0.47% | 25.67% | 30.29% | 24.15% |
Dividend Yield | 18.78% | - | 26.68% | 22.95% | 14.21% | 24.00% |
Payout Ratio | - | 31.26% | 14.01% | 11.63% | 88.57% | 7.77% |
Total Shareholder Return | 18.78% | - | 26.68% | 22.95% | 14.21% | 24.00% |